CDC reports the age‑adjusted U.S. drug overdose death rate fell 4% from 2022 to 2023 (31.3 per 100,000; 105,007 deaths). Rates declined for people 15–54 and for White non‑Hispanic people, but rose for adults 55+ and for Black non‑Hispanic and Native Hawaiian/Other Pacific Islander non‑Hispanic groups. Deaths involving synthetic opioids (e.g., fentanyl) decreased, while cocaine and psychostimulant‑involved deaths continued to rise.
— This shifts the overdose narrative beyond fentanyl, signaling a need to target rising stimulant harms and address growing demographic disparities in overdose risk.
EditorDavid
2026.09.05
70% relevant
Both items use long‑run, population‑level mortality datasets (Global Burden of Disease/provisional death records) to reveal shifting substance‑related mortality patterns; this article shows alcohol’s growing share of cancer deaths in the same way the existing idea tracked changing drug‑death patterns, implying similar policy conversations about substance regulation, harm reduction, and surveillance.
2026.01.04
92% relevant
The Wikipedia article is essentially a compiled, updated CDC time series showing the national overdose trajectory (peak ~2022, provisional counts for 2023–2025, role of synthetic opioids/fentanyl). That directly matches the existing idea’s claim that year‑to‑year shifts (including provisional declines and stimulant trends) require granular, disaggregated CDC data to interpret policy implications.
2026.01.04
72% relevant
The article reports a small decline in fentanyl deaths in 2023 (−1.4%) while warning about provisional 2024 undercounts; this links to the existing observation that overdose trends can shift year‑to‑year and that declines in one category can mask rises in others (stimulants, polysubstance involvement).
2025.10.07
100% relevant
CDC NCHS Data Brief No. 522 (NVSS, 2023): overall rate down 4%, fentanyl‑class deaths down, cocaine and psychostimulant deaths up, with age and race/ethnicity divergences.
2024.08.21
92% relevant
NIDA reports 105,007 overdose deaths in 2023 (down from 2022), opioid-involved deaths fell to 79,358, and deaths involving cocaine rose to 29,449 and psychostimulants to 34,855, with ~70% of stimulant deaths co‑involving illicit fentanyl—exactly the pattern described.
2023.03.08
80% relevant
The report documents large percentage increases in psychostimulant‑involved deaths (317% 2013–2019) and shows stimulants and cocaine rising even separate from synthetic‑opioid involvement, supporting the idea that the overdose crisis is diversifying beyond fentanyl.
2018.03.29
90% relevant
The MMWR furnishes the empirical basis for the later observation about shifting overdose composition: it documents the doubling of synthetic‑opioid deaths and increases in cocaine and psychostimulant deaths from 2015→2016, which is the early stage of the stimulant‑and‑synthetic‑opioid pattern the existing idea tracks.